Cargando…

Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double‐blind study

INTRODUCTION: Current hypnotic agents have next‐day residual effects. The new orexin antagonist, suvorexant, has little muscle relaxation effect on the physical and cognitive function in the following morning and daytime. In this study, the effects of suvorexant, zolpidem, ramelteon and placebo in e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uemura, Sachiko Ito, Imanishi, Aya, Terui, Yoshino, Park, Insung, Satake, Masahiro, Han, GoEun, Shioya, Takanobu, Kanbayashi, Takashi, Nishino, Seiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515713/ https://www.ncbi.nlm.nih.gov/pubmed/35748642 http://dx.doi.org/10.1002/npr2.12262

Ejemplares similares

Changes in sleep profile on exposure to sodium chloride and artificially carbonated springs: a pilot study
por: Uemura, Sachiko Ito, et al.
Publicado: (2023)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study
por: Ikeuchi, Shoya, et al.
Publicado: (2023)

Residual effects of eszopiclone and placebo in healthy elderly subjects: a randomized double-blind study
por: Takahashi, Jun, et al.
Publicado: (2017)

New evaluation of trunk movement and balance during walking in COPD patients by a triaxial accelerometer
por: Terui, Yoshino, et al.
Publicado: (2018)

Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
por: Iwata, Masaaki, et al.
Publicado: (2020)

Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users
por: Landry, Ishani, et al.
Publicado: (2022)

Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users
por: Landry, Ishani, et al.
Publicado: (2022)

Differential sleep/wake response and sex differences following acute suvorexant, MK‐1064 and zolpidem administration in the rTg4510 mouse model of tauopathy
por: Keenan, Ryan J., et al.
Publicado: (2022)

Dynamic hyperinflation and dyspnea during the 6-minute walk test in stable chronic obstructive pulmonary disease patients
por: Satake, Masahiro, et al.
Publicado: (2015)

Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015)

Ramelteon combined with an α(1)-blocker decreases nocturia in men with benign prostatic hyperplasia
por: Kawahara, Takashi, et al.
Publicado: (2013)

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
por: Ito, Hiroshi, et al.
Publicado: (2021)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation
por: Omori, Yuki, et al.
Publicado: (2018)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
por: Omori, Yuki, et al.
Publicado: (2018)

Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptoms
por: Shimizu, Nobutaka, et al.
Publicado: (2013)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Suvorexant for the prevention of delirium: A meta-analysis
por: Xu, Shu, et al.
Publicado: (2020)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011)

PT666. Check an effeciency About the Suvorexant with Combining Other Sleep Promoting Medicines
por: Akira Iwanami, Toshiaka Tsuneoka, et al.
Publicado: (2016)

Distinct effects of IPSU and suvorexant on mouse sleep architecture
por: Hoyer, Daniel, et al.
Publicado: (2013)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

PT653. Experience using suvorexant to treat delirium
por: Fujiwara, Kodo, et al.
Publicado: (2016)

(82) Effect of Suvorexant on COVID-19 Associated Delirium
por: Nazeer, Sahana, et al.
Publicado: (2022)

ZOLPIDEM INDUCED DELIRIUM
por: Sidana, Ajeet, et al.
Publicado: (2002)

Zolpidem withdrawal delirium
por: Mattoo, Surendra K., et al.
Publicado: (2011)

Zolpidem for the Treatment of Dystonia
por: Badillo, Stephanie Patricia J., et al.
Publicado: (2019)

Evaluation of the Anxiolytic Effect of Ramelteon in Various Rat Models of Anxiety
por: Nachiappan, KR, et al.
Publicado: (2023)

Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system
por: Ishido, Hideaki, et al.
Publicado: (2023)

Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia
por: Miwa, Kousei, et al.
Publicado: (2011)

Suvorexant improves intractable nocturnal enuresis by altering sleep architecture
por: Matsumoto, Tohru
Publicado: (2021)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

The Relief Effects of Ramelteon on Refractory Chronic Migraine: A Case Report
por: Hou, Yi-Cheng, et al.
Publicado: (2016)

Ramelteon Reduces Oxidative Stress by Maintenance of Lipid Homeostasis in Porcine Oocytes
por: Sun, Jing-Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lpv26npubnm50gl676tu3tbok6